Kontrol Technologies Corp N.KNR

Kontrol Biocloud Update

[wilander]

Kontrol Technologies to Deliver BioCloud Software Update Adds New Health Care Distribution Partner and Advances Replacement Cartridge Longevity

Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol” or the “Company”), a leader in smart building technology, is providing an updated version of the BioCloud operating software, adds a new health care distribution partner and advances the BioCloud replacement cartridge longevity.

“The most recent software update for BioCloud adds a number of new features based on customer feedback and demand. In addition, we have advanced the BioCloud technology to approximately double the longevity of the replacement cartridges,” said Paul Ghezzi, CEO of Kontrol Technologies. “We have learned a great deal from our operating units in the field and we continue to develop enhancements which are driven by the needs of our customers. We are also pleased to add a new health care distribution partner as BioCloud continues to attract global interest as a leading ambient air monitoring technology for viruses and pathogens.”

BioCloud Software Update

The updated version of the BioCloud software includes important improvements to the overall operation of the technology including advanced optical response data and analytics in real-time. Additional smart algorithms have been developed to map sensitivity against established baselines with the ability to reset baseline sensitivity in real-time. The software update will be issued as an OTA (over-the-air) update on or around December 13, 2021.

Replacement Cartridge Longevity Enhancement Reduces Operating Costs by up to 50%

Prior to the most recent software updates the BioCloud replacement cartridges were able to operate continuously until a singular positive viral or pathogen detection event. With the new version of the software the replacement cartridges can now be deployed for up to 2 detection events in the majority of cases.

“Our customers had requested that the BioCloud replacement cartridges be designed for potential multiple detection events. This important enhancement can effectively reduce the long-term operating costs of BioCloud by up to fifty percent,” said Gary Saunders, President of Kontrol BioCloud. “We are continuously working with our customers to deliver advances which are important to them and how they use the BioCloud technology.”

New Distribution Partner

Kontrol BioCloud has added a health organization in the Middle East as a new distribution partner. Under the terms of the distribution agreement the distribution partner will receive certain regional Government exclusivity for any Government orders for a period of up to 6 months. The new distribution partner operates health clinics in the Middle East with more than 20,000 doctors, healthcare workers and caregivers. The distribution partners name will remain confidential for industry competitive purposes.

[canyousayiii]

Moving in the right direction. Halving the cost of the cartridge is a significant step and needs to continue. They need to get the cost of the unit down significantly as well. I think it is clear to everyone that everyone would agree that when the technology is described, people think it is great, but I am pretty sure that the price tag prevents the vast majority from thinking it is great to

[navajojoe]

This post has been removed in accordance with Community Policy

[CTM1967]

lol Johnny come on ....if your BC is going off on a regular basis you have bigger problems and should probably look at your Covid protocols!!!!!!!!! they have already lowered the cartrige cost some time ago check NR's when they sorced the reagend from here in canada i think.......the new distro partner is ya no big deal ....the only thing is and what is different with this one is the fact that

[CTM1967]

as far as cost of the product goes yes it would be nice to have a lower pricetag the fact is that this is new and groundbreaking technology.... how much did the first personal computers cost/ flat screen TV's/ cell phones so alongside with BC being a new inovative product as well as groundbreaking in regards to a real time detector of a deadly virus i would say the pricetag at this point is

[canyousayiii]

The innovation and evolution of personal computers and such things has also evolved consumers' expectations. As you say, these things have gone from thousands of dollars to hundreds. That is why there won't be many jumping on the high price tags of new stuff and will wait for them to come down. I am thinking that mom and pop restaurants are not going to spend this amount of money right now

[CTM1967]

cant just rehash the missteps.... im over it ....time to move on ....they have implemented the option of the lease of the equipment to make it more cost effective for smaller buissness. and again its not a computer or phone this is equipment that can help prevent a serious illness or possibly death..is the pricetag worth it ??  how bout this scenario: company A tells their employees they

[canyousayiii]

CTM, so where are the sales? Could your employer use the BioCloud for the scenario you put forth? If so, did you tell them about it, did they buy it? I hear you, but unfortunately the current risk management for the vast majority of those that have heard of BioCloud does not include it. I would say that your view of the cost/benefit is not shared. A comparative outbreak situation is playing out in

[CTM1967]

thats what we are all trying to figure out SALES ....adoption of BC tech has been pretty well non existant due to vaccine push and only lately everyone getting on board with airisol transmission. BTW I work for myself so with no employees so on that fronnt the short answer is NO. having said that some of us have agreed that KNR has not done the best job promoting the new technology ...remember

[navajojoe]

This post has been removed in accordance with Community Policy

[Whydunnit]

BC should have been marketed to households from the start in addition to the B2B work.  I've said before that they should have done some advertising on the late national news (CTV, CBC).  Had they started that in the new year they would have sold a thousand already just to Canadian households, never mind the eyes they would have been opened among the thousands of business owners and